Butein is a novel anti-adipogenic compound

Journal of Lipid Research

Volumn 54, Issue 5, 2013, Pages 1385-1396

  Song, No Joon ^a   Yoon, Hyang Jin ^a   Kim, Ki Hyun ^a   Jung, So Ra ^a   Jang, Woo Seok ^a   Seo, Cho Rong ^a   Lee, Young Min ^b   Kweon, Dae Hyuk ^a   Hong, Joung Woo ^c   Lee, Jeong Soo ^d   Park, Ki Moon ^a   Lee, Kang Ro ^a   Park, Kye Won ^a  

^a Sungkyunkwan University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c Kyung Hee University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

3T3 L1; Adipocyte differentiation; Butein; C3H10T1 2; Genistein; Obesity; Peroxisome proliferator activated receptor ; Resveratrol; Rhus verniciflua Stokes

Indexed keywords

ANTIOBESITY AGENT; BUTEIN; CYCLIN D1; FATTY ACID BINDING PROTEIN 2; FISETIN; GENISTEIN; INHIBITOR OF DIFFERENTIATION 1; KRUPPEL LIKE FACTOR 5; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN P53; RESVERATROL; SMAD7 PROTEIN; STAT3 PROTEIN; SULFURETIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ANTIADIPOGENIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG POTENCY; DRUG STRUCTURE; EMBRYO; GENE EXPRESSION; INTRACELLULAR SIGNALING; LIPID STORAGE; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RHUS VERNICIFLUA; UPREGULATION;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHALCONES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, KNOCKOUT; OBESITY; PHOSPHORYLATION; RHUS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; STAT3 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 84876809828     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M035576     Document Type: Article

References (46)

1. Tontonoz, P., and B. M. Spiegelman. 2008. Fat and beyond: The diverse biology of PPARgamma. Annu. Rev. Biochem. 77 : 289-312.
2. Rosen, E. D., P. Sarraf, A. E. Troy, G. Bradwin, K. Moore, D. S. Milstone, B. M. Spiegelman, and R. M. Mortensen. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell. 4 : 611-617.
3. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferatoractivated receptor gamma (PPAR gamma). J. Biol. Chem. 270 : 12953-12956.
4. Waki, H., K. W. Park, N. Mitro, L. Pei, R. Damoiseaux, D. C. Wilpitz, K. Reue, E. Saez, and P. Tontonoz. 2007. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. Cell Metab. 5 : 357-370.
5. Hasani-Ranjbar, S., N. Nayebi, B. Larijani, and M. Abdollahi. 2009. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J. Gastroenterol. 15 : 3073-3085.
6. Jung, S. R., Y. J. Kim, A. R. Gwon, J. Lee, D. G. Jo, T. J. Jeon, J. W. Hong, K. M. Park, and K. W. Park. 2011. Genistein mediates the anti-adipogenic actions of Sophora japonica L. extracts. J. Med. Food. 14 : 360-368.
7. Baur, J. A., K. J. Pearson, N. L. Price, H. A. Jamieson, C. Lerin, A. Kalra, V. V. Prabhu, J. S. Allard, G. Lopez-Lluch, K. Lewis, et al. 2006. Resveratrol improves health and survival of mice on a highcalorie diet. Nature. 444 : 337-342.
8. Feige, J. N., M. Lagouge, C. Canto, A. Strehle, S. M. Houten, J. C. Milne, P. D. Lambert, C. Mataki, P. J. Elliott, and J. Auwerx. 2008. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 8 : 347-358.
9. Hung, P. F., B. T. Wu, H. C. Chen, Y. H. Chen, C. L. Chen, M. H. Wu, H. C. Liu, M. J. Lee, and Y. H. Kao. 2005. Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways. Am. J. Physiol. Cell Physiol. 288 : C1094-C1108.
10. Hwang, J. T., I. J. Park, J. I. Shin, Y. K. Lee, S. K. Lee, H. W. Baik, J. Ha, and O. J. Park. 2005. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 338 : 694-699.
11. Prior, R. L., X. Wu, L. Gu, T. Hager, A. Hager, S. Wilkes, and L. Howard. 2009. Purifi ed berry anthocyanins but not whole berries normalize lipid parameters in mice fed an obesogenic high fat diet. Mol. Nutr. Food Res. 53 : 1406-1418.
12. Shao, Z. M., Z. Z. Shen, C. H. Liu, M. R. Sartippour, V. L. Go, D. Heber, and M. Nguyen. 2002. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int. J. Cancer. 98 : 234-240.
13. Ejaz, A., D. Wu, P. Kwan, and M. Meydani. 2009. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J. Nutr. 139 : 919-925.
14. Jung, C. H., J. H. Kim, M. H. Hong, H. M. Seog, S. H. Oh, P. J. Lee, G. J. Kim, H. M. Kim, J. Y. Um, and S. G. Ko. 2007. Phenolic-rich fraction from Rhus vernicifl ua Stokes (RVS) suppress inflammatory response via NF-kappaB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages. J. Ethnopharmacol. 110 : 490-497.
15. Lee, J. C., K. T. Lim, and Y. S. Jang. 2002. Identification of Rhus vernicifl ua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochim. Biophys. Acta. 1570 : 181-191.
16. Jeon, W. K., J. H. Lee, H. K. Kim, A. Y. Lee, S. O. Lee, Y. S. Kim, S. Y. Ryu, S. Y. Kim, Y. J. Lee, and B. S. Ko. 2006. Anti-platelet effects of bioactive compounds isolated from the bark of Rhus vernicifl ua Stokes. J. Ethnopharmacol. 106 : 62-69.
17. Lee, S. H., J. X. Nan, Y. Z. Zhao, S. W. Woo, E. J. Park, T. H. Kang, G. S. Seo, Y. C. Kim, and D. H. Sohn. 2003. The chalcone butein from Rhus vernicifl ua shows antifi brogenic activity. Planta Med. 69 : 990-994.
18. Jeon, W. K., J. H. Kim, H. W. Lee, B. S. Ko, and H. K. Kim. 2003. Effects of Rhus vernicifl ua Stokes (RVS) extract on diet-induced obesity in C57BL/6 mouse. Kor. J. Pharmacognosy. 34 : 339-343.
19. Lee, J. C., K. Y. Lee, J. Kim, C. S. Na, N. C. Jung, G. H. Chung, and Y. S. Jang. 2004. Extract from Rhus vernicifl ua Stokes is capable of inhibiting the growth of human lymphoma cells. Food Chem. Toxicol. 42 : 1383-1388.
20. Kim, K. H., I. K. Lee, C. J. Piao, S. U. Choi, J. H. Lee, Y. S. Kim, and K. R. Lee. 2010. Benzylisoquinoline alkaloids from the tubers of Corydalis ternata and their cytotoxicity. Bioorg. Med. Chem. Lett. 20 : 4487-4490.
21. Park, K. W., H. Waki, S. P. Choi, K. M. Park, and P. Tontonoz. 2010. The small molecule phenamil is a modulator of adipocyte differentiation and PPARgamma expression. J. Lipid Res. 51 : 2775-2784.
22. Park, K. W., H. Waki, C. J. Villanueva, L. A. Monticelli, C. Hong, S. Kang, O. A. MacDougald, A. W. Goldrath, and P. Tontonoz. 2008. Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-gamma expression and adipocyte differentiation. Mol. Endocrinol. 22 : 2038-2048.
23. Jung, S. R., N. J. Song, H. S. Hwang, J. J. An, Y. J. Cho, H. Y. Kweon, S. W. Kang, K. G. Lee, K. Yoon, B. J. Kim, et al. 2011. Silk peptides inhibit adipocyte differentiation through modulation of the Notch pathway in C3H10T1/2 cells. Nutr. Res. 31 : 723-730.
24. Kuppusamy, U. R., and N. P. Das. 1994. Potentiation of beta-adrenoceptor agonist-mediated lipolysis by quercetin and fi setin in isolated rat adipocytes. Biochem. Pharmacol. 47 : 521-529.
25. Kim, S-G., D.-Y. Rhyu, D-K. Kim, D-H. Ko, Y-K. Kim, Y-M. Lee, and H-J. Jung. 2010. Inhibitory effect of heartwood of Rhus vernicifl ua Stokes on lipid accumulation in 3T3-L1 cells. Kor. J. Pharmacognosy. 41 : 21-25.
26. Rayalam, S., M. A. Della-Fera, J. Y. Yang, H. J. Park, S. Ambati, and C. A. Baile. 2007. Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J. Nutr. 137 : 2668-2673.
27. Rajendran, P., T. H. Ong, L. Chen, F. Li, M. K. Shanmugam, S. Vali, T. Abbasi, S. Kapoor, A. Sharma, A. P. Kumar, et al. 2011. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clin. Cancer Res. 17 : 1425-1439.
28. Pandey, M. K., B. Sung, K. S. Ahn, and B. B. Aggarwal. 2009. Butein suppresses constitutive and inducible signal transducer and activa-tor of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol. Pharmacol. 75 : 525-533.
29. Zhang, K., W. Guo, Y. Yang, and J. Wu. 2011. JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPbeta transcription. J. Cell. Biochem. 112 : 488-497.
30. Clarkson, R. W., M. P. Boland, E. A. Kritikou, J. M. Lee, T. C. Freeman, P. G. Tiffen, and C. J. Watson. 2006. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells defi ne the roles of these STATs in mammary development. Mol. Endocrinol. 20 : 675-685.
31. Starsichová, A., E. Lincová, Z. Pernicová, A. Kozubik, and K. Soucek. 2010. TGF-beta1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells. Cell. Signal. 22 : 1734-1744.
32. Nakao, A., T. Imamura, S. Souchelnytskyi, M. Kawabata, A. Ishisaki, E. Oeda, K. Tamaki, J. Hanai, C. H. Heldin, K. Miyazono, et al. 1997. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16 : 5353-5362.
33. Choy, L., J. Skillington, and R. Derynck. 2000. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J. Cell Biol. 149 : 667-682.
34. Gupta, S. C., J. H. Kim, S. Prasad, and B. B. Aggarwal. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 29 : 405-434.
35. Song, M. Y., G. S. Jeong, K. B. Kwon, S. O. Ka, H. Y. Jang, J. W. Park, Y. C. Kim, and B. H. Park. 2010. Sulfuretin protects against cytokine-induced beta-cell damage and prevents streptozotocininduced diabetes. Exp. Mol. Med. 42 : 628-638.
36. Song, M. Y., G. S. Jeong, H. S. Lee, K. S. Kwon, S. M. Lee, J. W. Park, Y. C. Kim, and B. H. Park. 2010. Sulfuretin attenuates allergic airway inflammation in mice. Biochem. Biophys. Res. Commun. 400 : 83-88.
37. Howitz, K. T., K. J. Bitterman, H. Y. Cohen, D. W. Lamming, S. Lavu, J. G. Wood, R. E. Zipkin, P. Chung, A. Kisielewski, L. L. Zhang, et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 425 : 191-196.
38. Lee, E. H., D. G. Song, J. Y. Lee, C. H. Pan, B. H. Um, and S. H. Jung. 2008. Inhibitory effect of the compounds isolated from Rhus vernicifl ua on aldose reductase and advanced glycation endproducts. Biol. Pharm. Bull. 31 : 1626-1630.
39. Kabututu, Z., M. Manin, J. C. Pointud, T. Maruyama, N. Nagata, S. Lambert, A. M. Lefrancois-Martinez, A. Martinez, and Y. Urade. 2009. Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7. J. Biochem. 145 : 161-168.
40. Fujimori, K., T. Ueno, N. Nagata, K. Kashiwagi, K. Aritake, F. Amano, and Y. Urade. 2010. Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase. J. Biol. Chem. 285 : 8880-8886.
41. Debnath, B., S. Xu, and N. Neamati. 2012. Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein. J. Med. Chem. 55 : 6645-6668.
42. Blobe, G. C., W. P. Schiemann, and H. F. Lodish. 2000. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342 : 1350-1358.
43. Choy, L., and R. Derynck. 2003. Transforming growth factorbeta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J. Biol. Chem. 278 : 9609-9619.
44. Alliston, T., L. Choy, P. Ducy, G. Karsenty, and R. Derynck. 2001. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 20 : 2254-2272.
45. Liu, D., B. L. Black, and R. Derynck. 2001. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15 : 2950-2966.
46. Patil, A. S., R. B. Sable, and R. M. Kothari. 2011. An update on transforming growth factor-beta (TGF-beta): Sources, types, functions and clinical applicability for cartilage/bone healing. J. Cell. Physiol. 226 : 3094-3103.